Life sciences · Journal article
Journal of Pharmaceutical Research International · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Infective endocarditis is a potentially life-threatening infection that may cause severe valvular and perivalvular complications, particularly when microbiological confirmation is not obtained. This case report describes a 42-year-old man who presented with progressive dyspnoea for one-month, intermittent fever, and haemoptysis, with New York Heart Association Class III functional limitation. Laboratory evaluation showed a C-reactive protein level of 73.893 mg/L, NT-proBNP of 7870 pg/mL, mild anaemia, and leucocytosis. Blood cultures remained negative after previous empirical antibiotic exposure. Chest radiography showed prominent bronchovascular markings, while high-resolution computed tomography demonstrated ground-glass opacities and patchy consolidation. Transthoracic and transoesophageal echocardiography identified multiple aortic valve vegetations, severe aortic regurgitation, and a paravalvular abscess with impending rupture. Empirical antimicrobial treatment was initiated with ceftriaxone and gentamicin, with vancomycin subsequently added; gentamicin was later discontinued. Supportive management included intravenous diuretics, ivabradine, oxygen supplementation, continuous positive airway pressure, electrolyte correction, and close clinical monitoring. Management was coordinated by cardiology and infectious disease specialists. Despite the severity of the structural cardiac findings, the patient demonstrated gradual clinical improvement with medical therapy, and surgery was not performed. The case highlights the diagnostic and management complexity of culture-negative infective endocarditis and the importance of timely echocardiographic assessment, appropriate empirical treatment, supportive care, and multidisciplinary evaluation.